STARVANIP
Mark Identification

STARVANIP

Serial Number

79276524

Filing Date

Nov 29, 2019

Registration Date

Oct 20, 2020

Trademark by

HAIM BIO CO. LTD.

Active Trademark

Classification Information

Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of cerebral apoplexy; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; immunomodulators; anti-inflammatories; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of deep vein thrombosis; drugs for medical purposes, namely, drugs for the treatment of cerebral apoplexy, drugs for affecting metabolism, drugs for affecting the peripheral nervous system, anti-inflammatory drugs, immunomodulatory drugs, cardiovascular drugs, drugs for treatment of deep vein thrombosis, drugs for treatment of systemic emboliform, drugs for treatment of venous thromboembolism, drugs affecting the central nervous system, drugs for treatment of pulmonary embolism, antibiotic drugs, drugs for the treatment of cancer, and drugs effecting respiratory organs; medicines for human purposes, namely, medicines for the treatment of cerebral apoplexy, medicines for affecting metabolism, medicines for affecting the peripheral nervous system, anti-inflammatory medicines, immunomodulatory medicines, cardiovascular medicines, medicines for treatment of deep vein thrombosis, medicines for treatment of systemic emboliform, medicines for treatment of venous thromboembolism, medicines affecting the central nervous system, medicines for treatment of pulmonary embolism, antibiotic medicines, medicines for the treatment of cancer or resistant cancer, and medicines effecting respiratory organs; pharmaceutical preparations for the treatment of systemic emboliform; pharmaceutical preparations for the treatment of venous thromboembolism; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of pulmonary emboliform; antibiotics; anti-cancer preparations; pharmaceutical preparations for respiratory organs

Pharmaceuticals